mGluR1 expression might be a good prognostic marker in predicting patient survival in estrogen receptor (ER)-positive, ER-negative, and triple-negative breast cancers (TNBC) [102,103,104]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.